Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

In patients without diabetes who are obese, a once-weekly injection of tirzepatide (Mounjaro, Eli Lilly) may help shed weight and improve some risk factors for CVD, including blood pressure and ...

SURMOUNT (“the firm”), a leading full-service net lease real estate advisory and investment platform, today announced the completion of a $17.7 million net lease industrial transaction in Janesville, ...

SURMOUNT, the industry-leading full-service net lease real estate advisory and investment platform, today announced that it ...

Please provide your email address to receive an email when new articles are posted on . Adults receiving tirzepatide 10 mg or 15 mg lost more than 13% of their body weight at 72 weeks. A little more ...

SAN DIEGO — Weekly tirzepatide injections in adults with type 2 diabetes and overweight or obesity safely led to 12.8%-14.7% in-trial weight loss after 72 weeks in the SURMOUNT-2 pivotal trial, a ...

LOS ANGELES, February 05, 2026--(BUSINESS WIRE)--SURMOUNT, a leading full-service net lease real estate advisory and investment platform, announced today that Scott Budzenski has joined the firm as ...

The unstoppable march of Eli Lilly’s tirzepatide continues. Having previously shown the dual GIP/GLP-1 agonist reduces the weight of people with diabetes, Lilly has now delivered a hit in its first ...

Developers Indiana-Jonas and Jasper Oprel announced the free-flowing, physics-based platforming adventure game, Surmount, will launch for the Nintendo Switch and PC via Steam and Epic Games Store on ...

The firm represented both buyer and seller in the acquisition of a 264,793-square-foot industrial facility SURMOUNT (“the firm”), a leading full-service net lease real estate advisory and investment ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At 72 weeks, adults receiving 10 mg tirzepatide lost ...